INM
InMed Pharmaceuticals Inc.
NASDAQ · Healthcare · Biotechnology · CA
$1.38
+3.76%Leverage
- Debt / equity
- 0.06x
- Net debt / equity
- -0.69x
- Debt / assets
- 0.05x
- Debt / EBITDA
- -0.05x
- Net debt / EBITDA
- 0.51x
Liquidity & coverage
- Current ratio
- 3.11x
- Quick ratio
- 3.11x
- Cash ratio
- 2.35x
- Interest coverage
- -496.36x
- EBITDA / interest
- -461.60x
- Working capital
- $4.7M
Cash & dividend
- FCF / debt
- -21.44x
- Cash flow / debt
- -21.44x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Mar 1, 2026